International Business Machines (IBM)

Key Updates

IBM shares have extended their post-earnings pullback, declining an additional 2.19% to $216.88 since the July 30 report at $221.74, eroding a portion of the recovery from the July 24 trough near $205.72. With no new material disclosures since the Q2 earnings release, the price action reflects continued digestion of the lowered full-year guidance and 42% mainframe revenue collapse. The investment thesis remains under pressure, though the maintained free cash flow outlook and new z17 product introductions provide partial fundamental offsets.

Current Trend

The intermediate trend is decisively negative. YTD performance stands at -26.78%, with the 1-month decline of -24.23% driven by the post-earnings gap down on July 22. Following a rebound of approximately 10.6% from the July 24 low near $205.72 to a recovery high around $227.55 on July 28, the stock has since faded back toward $216.88. This price action establishes near-term resistance in the $221-$228 band and leaves the July 24 low as critical support. The 5-day performance of +1.26% shows minor volatility within the broader downtrend, while the 6-month decline of -29.29% confirms sustained distribution.

Investment Thesis

The thesis is challenged by a structural reallocation of enterprise capital budgets away from IBM's core mainframe and software franchises toward AI infrastructure, resulting in a 42% plunge in IBM Z sales and a 7% drop in infrastructure revenue. The company lowered its FY2026 revenue growth outlook to 4-5% at constant currency, down from prior expectations above 5%, with reported growth now expected near zero due to foreign exchange headwinds. Offsetting factors include management's maintenance of free cash flow guidance for an approximate $1 billion increase this year and the launch of compact z17 mainframes and LinuxONE 5 servers powered by the Telum II processor, which target on-premises enterprise AI inference workloads. The stock's 26.78% YTD decline suggests significant pessimism is already priced in, but a durable reversal requires evidence that new product cycles can reignite organic software and infrastructure demand.

Thesis Status

The thesis remains impaired. The Q2 revenue and adjusted EPS miss, combined with the guidance reduction, validate bearish concerns regarding demand elasticity in IBM's legacy segments. The flat organic software growth and 42% mainframe collapse indicate that the anticipated AI monetization has not yet offset cannibalization of traditional spending. However, the unchanged free cash flow target suggests management does not expect a fundamental deterioration in cash generation, and the new hardware cycle offers a tangible catalyst for the second half. Until consulting and software demonstrate sustained organic acceleration, the status remains defensive.

Key Drivers

The primary driver remains the Q2 earnings disappointment and guidance reduction disclosed on July 22, where revenue of $17.16 billion (+1% YoY) missed the $17.58 billion consensus and adjusted EPS of $2.93 fell short of the $2.97 estimate (SiliconANGLE, July 22). The 42% plunge in IBM Z mainframe sales and 7% decline in infrastructure revenue to $3.84 billion reflect a customer shift in capital allocation toward AI infrastructure (SiliconANGLE, July 22). Software revenue rose 5% to $7.76 billion but was flat excluding acquisitions, while consulting revenue increased 1% at constant currency to $5.3 billion (SiliconANGLE, July 22). On the product front, IBM debuted compact z17 mainframes and LinuxONE 5 servers featuring the Telum II processor with 10% single-threaded performance gains and up to 20% greater overall capacity, targeting on-premises AI inference and quantum-safe security requirements (SiliconANGLE, July 7). Official filings with the SEC, including the Form 10-Q for the period ended June 30, 2026, confirmed net income of $2.17 billion (down 1% YoY) and diluted EPS of $2.27 (down 2% YoY) (SEC EDGAR, July 22).

Technical Analysis

Current price action at $216.88 reflects a failed recovery attempt within a primary downtrend. The post-earnings low near $205.72 on July 24 serves as the immediate support level; a break below this would open the door to further downside. Resistance is now well-defined in the $221.74-$227.55 zone, with the July 28 high marking the upper bound. The stock's position well below all recent reference points indicates that supply remains in control. Volume dynamics are not provided, but the sequential lower highs following the rebound suggest fading conviction among buyers.

Bull Case

• Management maintained guidance for free cash flow to increase by approximately $1 billion in FY2026, signaling confidence in cash generation resilience despite the revenue and earnings miss. (SiliconANGLE, July 22)
• IBM launched compact z17 mainframes and LinuxONE 5 servers powered by the Telum II processor, delivering 10% single-threaded and 20% overall capacity improvements to target on-premises enterprise AI inference and regulated workloads. (SiliconANGLE, July 7)
• Software revenue grew 5% year-over-year to $7.76 billion, providing a stable revenue base even as infrastructure sales contracted sharply. (SiliconANGLE, July 22)
• The LinuxONE Rockhopper 5 can replace the workload of 23 comparable x86 servers while reducing power consumption by up to 83%, offering a compelling total cost of ownership argument for enterprise data centers. (SiliconANGLE, July 7)
• Consulting revenue increased 1% at constant currency to $5.3 billion, demonstrating modest resilience in the services segment despite broader IT spending headwinds. (SiliconANGLE, July 22)

Bear Case

• IBM lowered its FY2026 revenue growth forecast to 4-5% at constant currency, down from a prior outlook of more than 5%, with reported growth now expected close to zero due to foreign exchange headwinds. (SiliconANGLE, July 22)
• IBM Z mainframe sales plunged 42% year-over-year, and infrastructure revenue fell 7% to $3.84 billion as customers diverted capital budgets toward AI infrastructure. (SiliconANGLE, July 22)
• Second-quarter revenue of $17.16 billion and adjusted EPS of $2.93 both missed consensus expectations of $17.58 billion and $2.97, respectively, while net income edged down 1% to $2.17 billion. (SiliconANGLE, July 22)
• Software revenue was flat excluding acquisitions, indicating a lack of organic growth in what is typically viewed as the company's most stable segment. (SiliconANGLE, July 22)
• Net income declined 1% year-overyear-over-year to $2.17 billion and diluted EPS decreased 2% to $2.27, as formally disclosed in the quarterly SEC filing, corroborating the earnings compression evident in the headline results. (SEC EDGAR, July 22)